Asparaginase activity monitoring experience from the Maritimes, Canada

Leuk Lymphoma. 2019 Sep;60(9):2312-2315. doi: 10.1080/10428194.2019.1571196. Epub 2019 Feb 5.

Authors

Meghan Pike¹, Ketan Kulkarni², Tamara MacDonald³

Affiliations

¹ Department of Pediatrics, Dalhousie University/IWK Health Centre , Halifax , Nova Scotia , Canada.
² Department of Pediatrics/Division of Pediatric Hematology-Oncology, Dalhousie University/IWK Health Centre , Halifax , Nova Scotia , Canada.
³ Department of Pharmacy, Faculty of Health Professions, Dalhousie University/IWK Health Centre , Halifax , Nova Scotia , Canada.

PMID: 30721104
DOI: 10.1080/10428194.2019.1571196

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Antineoplastic Agents / blood*
Antineoplastic Agents / therapeutic use
Asparaginase / blood*
Asparaginase / therapeutic use
Canada
Child
Child, Preschool
Drug Monitoring / methods
Drug Monitoring / statistics & numerical data*
Female
Humans
Male
Polyethylene Glycols / therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Prospective Studies
Remission Induction / methods

Substances

Antineoplastic Agents
Polyethylene Glycols
pegaspargase
Asparaginase